vs

Side-by-side financial comparison of Inspire Medical Systems, Inc. (INSP) and Sprout Social, Inc. (SPT). Click either name above to swap in a different company.

Inspire Medical Systems, Inc. is the larger business by last-quarter revenue ($204.6M vs $120.9M, roughly 1.7× Sprout Social, Inc.). On growth, Sprout Social, Inc. posted the faster year-over-year revenue change (12.9% vs 1.6%). Over the past eight quarters, Sprout Social, Inc.'s revenue compounded faster (11.8% CAGR vs 2.2%).

Inspire Medical Systems, Inc. is a medical technology firm that develops, manufactures and commercializes implantable neurostimulation solutions for obstructive sleep apnea. Its core product serves patients intolerant to CPAP therapy, with main markets across North America, Europe, and select Asia-Pacific regions, operating in sleep medicine and otolaryngology segments.

Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.

INSP vs SPT — Head-to-Head

Bigger by revenue
INSP
INSP
1.7× larger
INSP
$204.6M
$120.9M
SPT
Growing faster (revenue YoY)
SPT
SPT
+11.3% gap
SPT
12.9%
1.6%
INSP
Faster 2-yr revenue CAGR
SPT
SPT
Annualised
SPT
11.8%
2.2%
INSP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
INSP
INSP
SPT
SPT
Revenue
$204.6M
$120.9M
Net Profit
Gross Margin
86.5%
77.6%
Operating Margin
13.0%
-9.0%
Net Margin
Revenue YoY
1.6%
12.9%
Net Profit YoY
EPS (diluted)
$-0.39
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INSP
INSP
SPT
SPT
Q1 26
$204.6M
Q4 25
$269.1M
$120.9M
Q3 25
$224.5M
$115.6M
Q2 25
$217.1M
$111.8M
Q1 25
$201.3M
$109.3M
Q4 24
$239.7M
$107.1M
Q3 24
$203.2M
$102.6M
Q2 24
$195.9M
$99.4M
Net Profit
INSP
INSP
SPT
SPT
Q1 26
Q4 25
$136.1M
Q3 25
$9.9M
$-9.4M
Q2 25
$-3.6M
$-12.0M
Q1 25
$3.0M
$-11.2M
Q4 24
$35.2M
Q3 24
$18.5M
$-17.1M
Q2 24
$9.8M
$-16.9M
Gross Margin
INSP
INSP
SPT
SPT
Q1 26
86.5%
Q4 25
86.6%
77.6%
Q3 25
85.8%
77.7%
Q2 25
84.0%
77.7%
Q1 25
84.7%
77.3%
Q4 24
85.0%
78.1%
Q3 24
84.1%
77.4%
Q2 24
84.8%
77.5%
Operating Margin
INSP
INSP
SPT
SPT
Q1 26
13.0%
Q4 25
17.1%
-9.0%
Q3 25
4.3%
-7.9%
Q2 25
-1.5%
-11.0%
Q1 25
-0.7%
-10.2%
Q4 24
13.3%
-12.8%
Q3 24
7.0%
-16.4%
Q2 24
2.6%
-16.6%
Net Margin
INSP
INSP
SPT
SPT
Q1 26
Q4 25
50.6%
Q3 25
4.4%
-8.1%
Q2 25
-1.7%
-10.7%
Q1 25
1.5%
-10.3%
Q4 24
14.7%
Q3 24
9.1%
-16.6%
Q2 24
5.0%
-17.0%
EPS (diluted)
INSP
INSP
SPT
SPT
Q1 26
$-0.39
Q4 25
$4.57
$-0.18
Q3 25
$0.34
$-0.16
Q2 25
$-0.12
$-0.21
Q1 25
$0.10
$-0.19
Q4 24
$1.17
$-0.25
Q3 24
$0.60
$-0.30
Q2 24
$0.32
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INSP
INSP
SPT
SPT
Cash + ST InvestmentsLiquidity on hand
$98.9M
$95.3M
Total DebtLower is stronger
$40.0M
Stockholders' EquityBook value
$792.3M
$203.4M
Total Assets
$911.4M
$523.1M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INSP
INSP
SPT
SPT
Q1 26
$98.9M
Q4 25
$308.3M
$95.3M
Q3 25
$322.6M
$90.6M
Q2 25
$300.9M
$101.5M
Q1 25
$369.2M
$100.9M
Q4 24
$445.5M
$86.4M
Q3 24
$411.0M
$82.9M
Q2 24
$439.7M
$80.9M
Total Debt
INSP
INSP
SPT
SPT
Q1 26
Q4 25
$40.0M
Q3 25
Q2 25
Q1 25
Q4 24
$25.0M
Q3 24
Q2 24
Stockholders' Equity
INSP
INSP
SPT
SPT
Q1 26
$792.3M
Q4 25
$781.2M
$203.4M
Q3 25
$666.5M
$194.1M
Q2 25
$677.8M
$184.6M
Q1 25
$635.7M
$175.3M
Q4 24
$689.7M
$166.6M
Q3 24
$696.6M
$158.1M
Q2 24
$638.1M
$152.1M
Total Assets
INSP
INSP
SPT
SPT
Q1 26
$911.4M
Q4 25
$907.3M
$523.1M
Q3 25
$807.7M
$481.4M
Q2 25
$802.2M
$422.9M
Q1 25
$730.8M
$424.7M
Q4 24
$808.4M
$428.3M
Q3 24
$796.2M
$388.8M
Q2 24
$728.4M
$393.6M
Debt / Equity
INSP
INSP
SPT
SPT
Q1 26
Q4 25
0.20×
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INSP
INSP
SPT
SPT
Operating Cash FlowLast quarter
$10.9M
Free Cash FlowOCF − Capex
$9.9M
FCF MarginFCF / Revenue
8.2%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$39.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INSP
INSP
SPT
SPT
Q1 26
Q4 25
$52.5M
$10.9M
Q3 25
$68.5M
$9.3M
Q2 25
$2.7M
$5.1M
Q1 25
$-6.7M
$18.1M
Q4 24
$69.2M
$4.1M
Q3 24
$52.3M
$9.0M
Q2 24
$-78.0K
$2.1M
Free Cash Flow
INSP
INSP
SPT
SPT
Q1 26
Q4 25
$41.8M
$9.9M
Q3 25
$58.1M
$8.5M
Q2 25
$-6.3M
$4.2M
Q1 25
$-15.1M
$16.7M
Q4 24
$62.2M
$3.3M
Q3 24
$44.3M
$8.5M
Q2 24
$-12.5M
$1.6M
FCF Margin
INSP
INSP
SPT
SPT
Q1 26
Q4 25
15.5%
8.2%
Q3 25
25.9%
7.4%
Q2 25
-2.9%
3.7%
Q1 25
-7.5%
15.3%
Q4 24
25.9%
3.0%
Q3 24
21.8%
8.3%
Q2 24
-6.4%
1.6%
Capex Intensity
INSP
INSP
SPT
SPT
Q1 26
Q4 25
4.0%
0.9%
Q3 25
4.6%
0.7%
Q2 25
4.1%
0.8%
Q1 25
4.2%
1.2%
Q4 24
2.9%
0.8%
Q3 24
3.9%
0.5%
Q2 24
6.3%
0.5%
Cash Conversion
INSP
INSP
SPT
SPT
Q1 26
Q4 25
0.39×
Q3 25
6.90×
Q2 25
Q1 25
-2.24×
Q4 24
1.96×
Q3 24
2.83×
Q2 24
-0.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons